Industry

Review of pediatric antidepressant studies finds the vast majority are negative on primary outcomes and an increased risk for suicidality.

A study in BMC Psychiatry explores a range of perspectives on the value of neuroimaging studies for disorders of mental health. The study concludes...

As patents expire on current antidepressants pharmaceutical companies are getting out of the market, according to an article in yesterday's Vancouver Sun. In the latest...

The Seventh Circuit Court of Appeals yesterday rejected a lower court's dismissal of  Watson v. King-Vassel, saying that a jury is in fact sufficiently able...

I believe the video ‘Voices Matter’ has, quite apart from capturing the spirit of the Hearing Voices movement, filmed the first signs, the first moments of professional interest, hinting at the dangers that inevitably are present when a movement threatens the established order of things.

The Washington Post profiles Daniel Amen, "the most popular psychiatrist in America," who claims in copious books, DVDs, television and speaking engagements to be...

The FDA has released a new checklist meant to clarify the ways a pharmaceutical manufacturer may use scientific and medical literature to promote products....

New study finds that pharmaceutical industry gifts to medical providers in Washington D.C. are associated with higher cost, higher volume prescribing behavior.

With the ties between traumatic childhood experiences and mental health issues, should we continue to focus on biological approaches?

From The Wire: Xtandi, a life-prolonging cancer drug, currently does not have a patent in India, meaning that Indian cancer patients are able to access...

Researchers from the City College of New York and Columbia University published a study this month testing the hypothesis that people diagnosed with schizophrenia treated long-term with antipsychotic drugs have worse outcomes than patients with no exposure to these drugs. They concluded that there is not a sufficient evidence base for the standard practice of long-term use of antipsychotic medications.

Researchers from Philadelphia and Baltimore find, in a study of Medicaid records for 50 states and the District of Columbia, that antipsychotic prescribing to...

A new study links direct-to-consumer (DTC) advertising to increased testosterone treatment, even when patients do not have a diagnosable condition.

In a review article for this month’s American Journal of Psychiatry, Daniel Weinberger and Eugenia Radulescu from John Hopkins University push back against the overreliance on MRI scans in recent psychiatric studies. While acknowledging that they both have contributed to this type of research in the past, the authors warn that “findings” from these studies “pose a serious risk of misinforming our colleagues and our patients.”

-Is the World Health Organization moving towards developing tighter ties with corporations through its new "Framework of Engagement with non-State Actors"?

Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...

William A. Wilson presents shocking evidence that a lot of published research is false and that science’s self-correcting mechanisms are broken. “There is no...

From the New Scientist: “Paul Smaldino and Richard McElreath at the University of California Davis used an evolutionary theory-based computational model to analyse the problem of bad...

In early 2009, antipsychotic fraud was making headlines.  Eli Lilly had announced in January that it would plead guilty to charges that it had...

The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

Meta-analyses fail to replicate findings linking abnormal brain activity to depression.